(Q27008949)

Carlo Maria Rotella

series ordinal

3

1 reference

language of work or name

1 reference

2012

1 reference

Experimental Diabetes Research

17 June 2012

4 references

6 October 2019

11 October 2019

17 November 2019

26 January 2021

5 references

6 October 2019

11 October 2019

17 November 2019

26 January 2021

2012

1 reference

page(s)

519784

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

4 references

6 October 2019

11 October 2019

17 November 2019

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

26 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

The Physiology of Glucagon-like Peptide 1

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Receptors and effects of gut hormones in three osteoblastic cell lines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Vitamin D and calcium: a systematic review of health outcomes.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Diabetes and fractures: an overshadowed association

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Impact of glucose-dependent insulinotropic peptide on age-induced bone loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Potential role of pancreatic and enteric hormones in regulating bone turnover.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Is Calcitonin an Important Physiological Substance?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385656

Role of gastrointestinal hormones in postprandial reduction of bone resorption

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Mechanism of circadian variation in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Vitamin D deficiency is not good for you.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Glucagon-like peptide-1 binding to rat hepatic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Peptide YY regulates bone turnover in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Four-month treatment with GLP-2 significantly increases hip BMD

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F519784

21 January 2018

Vitamin D and Diabetes

1 reference

12 December 2020

Vitamin D therapy in adults with diabetes mellitus

1 reference

12 December 2020

GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia

1 reference

12 December 2020

Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus

1 reference

12 December 2020

Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women

1 reference

12 December 2020

Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study

1 reference

12 December 2020

Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow

1 reference

12 December 2020

Identifiers

1 reference

1 reference

PubMed publication ID

22761607

1 reference